Phase I--II trial design for biologic agents using conditional auto-regressive models for toxicity and efficacy (Q6642058)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Phase I--II trial design for biologic agents using conditional auto-regressive models for toxicity and efficacy |
scientific article; zbMATH DE number 7947983
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I--II trial design for biologic agents using conditional auto-regressive models for toxicity and efficacy |
scientific article; zbMATH DE number 7947983 |
Statements
Phase I--II trial design for biologic agents using conditional auto-regressive models for toxicity and efficacy (English)
0 references
21 November 2024
0 references
biologically optimal dose
0 references
clinical trial
0 references
dose finding
0 references
immunotherapy
0 references
molecularly targeted agent
0 references
randomization
0 references
